跳至主要内容
临床试验/2024-518028-63-00
2024-518028-63-00招募中2 期

Maternal Mental Health (MAMA) Study. Short time estrogen as a candidate strategy to prevent postpartum depression in a high-risk group

Rigshospitalet4 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2024年10月8日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
220
试验地点
4
主要终点
Clinical depression according to DSM-V criteria. Between 2 weeks and 6 months postpartum

研究概览

简要总结

To evaluate if short-term estradiol administration relative to placebo in the immediate postpartum period (day 0 to day 21) prevents depressive episodes in women with a history of postpartum depression

研究设计

研究类型
Interventional

入排标准

年龄范围
0 years 至 64 years(0-17 Years, 18-64 Years)
接受健康志愿者

入选标准

  • Women between 18 and 45 years and pregnant in the third trimester.
  • Previously perinatal depression with the onset of depressive episode in pregnancy or within 6 months of birth or untreated depressive episode assessed by retrospective interview by healthcare professional.

排除标准

  • Antidepressant treatment by inclusion in the study.
  • Pregnancy-related hypertension or preeclampsia.
  • Manifest atherosclerosis or known cardiovascular risk factors (including diabetes, hypertension).
  • Other contraindication for estrogen treatment (e.g. acute liver disease, varicicated varicencies).
  • Use of psychotropic pharmacology, except for short-term sleep support treatment, which is likely to influence the results of the study.
  • Non-fluent in Danish or pronounced vision or hearing loss.
  • Current or previous learning difficulties.
  • BMI >35 kg/m
  • Current alcohol or drug abuse.
  • Multiple pregnancy.
  • Severe postpartum haemorrhage (>1500 ml).
  • Moderate to severe depression developed in pregnancy before day 0 postpartum.
  • Serious illness or neonatal death in the child.
  • Severe mental illness, e.g. diseases of the schizophrenic spectrum, psychotic conditions, inpatient active eating disorder or hospitalising OCD, and bipolar affective disorder.
  • Previous suicide attempts outside the depressive episode.
  • Present or previous neurological disease including migraines and epilepsy.
  • Severe medical disease.
  • Past or ongoing cancer.
  • Previous venous thromboembolism, myocardial infarction, cerebrovascular thromboembolism or known thrombophilic diseases and risk factors clinically assessed after thrombophilic screening.
  • Deep vein thrombosis or pulmonary embolism in current pregnancy.

结局指标

主要结局

Clinical depression according to DSM-V criteria. Between 2 weeks and 6 months postpartum

Clinical depression according to DSM-V criteria. Between 2 weeks and 6 months postpartum

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Vibe Gedsoe Froekjaer

Scientific

Rigshospitalet

研究点 (4)

Loading locations...

相似试验